Denosumab bulk supplier for pharma manufacturers

Denosumab Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 60 mg/mL, 120 mg/1.7 mL

Reference Brands: Prolia, Xgeva

Category: Osteoporosis

Denosumab is available in Injection and strengths such as 60 mg/mL, 120 mg/1.7 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Denosumab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Denosumab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description: Denosumab is a leading RANKL-inhibiting monoclonal antibody used in the treatment of osteoporosis, cancer-related bone loss, and bone metastases. Available as a 60 mg/mL prefilled syringe (Prolia®) for biannual dosing and 120 mg/1.7 mL (Xgeva®) for monthly administration, Denosumab offers effective and long-acting bone protection. Trusted globally under Amgen's Prolia and Xgeva brands, it is approved across the US and EU. Denosumab is manufactured in GMP-certified facilities and is available for B2B pharmaceutical distribution, including hospitals and oncology clinics. Contact us for bulk export, COAs, and regulatory documentation.

Frequently Asked Questions

Yes, Denosumab is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Denosumab is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Secukinumab

Strength: 150 mg/mL

Form: Injection

Reference Brands: Cosentyx

View Details
Zoledronic Acid

Strength: 5 mg/100 mL, 4 mg/5 mL (reconstituted)

Form: Injection

Reference Brands: Reclast, Zometa,Aclasta,

View Details
Calcium Citrate + Alfacalcidol + Zinc Sulphate Tablet

Strength: 1000mg + 0.25mcg + 7.5mg

Form: Tablets

Reference Brands:

View Details
Calcium Carbonate Oral Suspension

Strength: 250mg/5ml

Form: Tablets

Reference Brands:

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.